ACE inhibitors are justly regarded as the most important advance in cardiac drug therapy. Acting basically as inhibitors of the renin-angiotensin system, these agents have grown in importance to become among the therapeutic agents of first choice for hypertension, and the cornerstone of therapy in congestive heart failure. Recent studies show that they can also prevent post-infarct heart failure and reinfarction, and beneficially influence diabetic and non-diabetic renal lesions. The major aim of this book is to present the clinician with the information needed for the practical and discerning use of ACE inhibitors. A new chapter emphasises the advances in molecular biology that explain the vascular protective effect of ACE inhibitors while another outlines emerging indications in diabetic and non-diabetic renal disease. New trials include ABCD, AIREX, ATLAS, CAPP and REIN, with speculative predictions for PROGRESS, HOPE, PEACE and others.
"synopsis" may belong to another edition of this title.
Book Description University of Cape Town Press, 1998. Paperback. Book Condition: Used: Like New. Like new, softcover UNREAD, slight shelf wear, Satisfaction Guaranteed, International Shipping, Photos upon request. Bookseller Inventory # SKU0220233